Preferred Name |
gadodiamide |
Synonyms |
Gd-DTPA-BMA |
ID |
http://purl.bioontology.org/ontology/MESH/C064925 |
altLabel |
Gd-DTPA-BMA Gadolinium, aqua(5,8-bis(carboxymethyl)-11-(2-(methylamino)-2-oxoethyl)-3-oxo-2,5,8,11-tetraazatridecan-13-oato(3-))-, hydrate Omniscan Omniscan Unique Softpack Gd-DTPA bis-(methylamide) |
cui |
C0722252 C0082646 |
HM |
D019786 |
II |
D007275 |
Inverse of RB |
84F6U3J2R6 |
isa | |
LT |
TRD |
Mapped to | |
MDA |
19900815 |
MeSH Frequency |
1283 |
MMR |
20161222 |
notation |
C064925 |
PA |
D003287 |
PI |
*DTPA (90-93) *ORGANOMETALLIC COMPOUNDS (94-97) DTPA/*analogs & derivatives (94-97) |
prefLabel |
gadodiamide |
RR |
122795-43-1 |
SC |
1 |
Scope Statement |
for intravenous administration with MRI in adult patients for contrast enhancement of CNS lesions |
SRC |
Radiology 1990;176(2):451 |
TERMUI |
T208727 T208728 T208730 T635724 T208729 |
TH |
FDA SRS (2015) USAN (1990) US DE NLM (1990) CA AU INN (19XX) ES |
tui |
T109 T130 |